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Bone regenerationAbstract Objective: To evaluate bone regeneration in a heterogenous, deproteinized bone mineral
(DBM) when used as an onlay graft.
Materials and methods: In this study, eight rabbits received two titanium bone graft holders
(TBGHs), one on the left and one on the right lateral surface of the mandible. Each TBGH pos-
sessed two cylindrical chambers, which were perforated with numerous sub-millimeter pores. On
the experimental side of the jaw, the chambers were ﬁlled with DBM particles (Bio-Oss, Geistlich
Pharmaceutical AG, Walhusen, Switzerland). Chambers on the opposite (control) side of the jaw
were empty (no DBM). Following TBGH placement both the control and experimental TBGHs
were covered with a barrier layer of collagen membrane (Bio-Gide, Geistlich Pharmaceutical
AG, Walhusen, Switzerland). After twelve weeks, sections of the mandible were harvested for radio-
graphic and histomorphometric evaluation.
Results: New bone formation was seen in both test and control chambers. However, the newly
generated bone was greater in the experimental (DBM) group (18.41%) than in the control group
(5.31%). The difference was statistically signiﬁcant (p< 0.001). Upon quantiﬁcation of the radio-
dense area from the radiographs, there was signiﬁcantly more bone and/or graft in the experimental
group (12.96 mm2 ± 1.48) than the control group (8.59 mm2 ± 3.54) (p< 0.001). Similarly, the
DBM chambers were ﬁlled to a signiﬁcantly greater height (2.73 mm± 0.24) than the control
chambers (1.83 mm± 0.72) (p< 0.001).
134 B.A. Al-jandan et al.Conclusion: DBM can enhance greater new bone formation when used as an onlay graft, under-
neath a rigid barrier.
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Placement of endosseous dental implants can be complicated
by inadequate bone volume resulting from tooth loss,
periodontal disease, trauma, or pathosis 1,2,3. In such cases,
bone or bone substitutes are often used to augment deﬁcient
alveolar bone 4. Autogenous bone is considered the ‘‘gold
standard’’, for alveolar ridge regeneration, due to its
osteogenic, osteoconductive and osteoinductive properties 5.
However, autogenous bone grafts are associated with donor
site morbidity and in some situations a rapid rate of
resorption 6. In addition, autogenous bone block or particu-
lates can be ﬁxed to or laid on the outer surface of the
recipient site known as onlay graft 5. Since it is still limited
in supply, there is increasing interest in the use of allogenic,
xenogenic and alloplastic materials, for alveolar ridge regen-
eration 7,8.
Xenografts used for guided bone regeneration in the
maxillofacial region are most commonly of bovine origin 4.
Bio-Oss (Geistlich Pharmaceutical AG, Walhusen, Switzer-
land) is a natural deproteinized bovine bone mineral (DBM)
derivative without an organic component 9. DBM and miner-
alized human bone are comparable in their chemical and mor-
phological structures 10.
Although there are multiple studies that evaluated the
osteoconductivity of DBM, still few studies quantiﬁed the
amount of generated bone. Two experimental studies evalu-
ated the amount of bone generation in Teﬂon capsules
grafted with DBM as compared to empty (control) capsules
11,12. The capsules were ﬁxed to the mandible of the rat using
suture material. In both experiments, it was shown by histo-
morphometric analysis that DBM had an inhibitory effect on
bone formation. Similarly, in an experiment involving cranial
defects in the rat, Slotte and Lundgren 13 reported reduced
bone formation in silicone domes ﬁlled with DBM, when
compared to empty (control) domes. In contrast, other stud-
ies have reported that DBM enhances bone generation. In an
experiment involving cranial defects in the rabbit, Slotte and
Lundgren 14 examined the bone formation in titanium cylin-
ders ﬁlled with either autogenous bone or DBM and com-
pared the response to empty titanium cylinders (controls).
Signiﬁcantly more bone tissue was found in the two test
groups than the control group. Similarly, Veis and Dabarakis
15 evaluated DBM in both particulate, and block forms in
vertical augmentation of the buccal bony plates of the outer
mandibles of New Zealand rabbits. The authors found posi-
tive results with both forms with no statistically signiﬁcant
difference.
Since there is a disagreement among experimental studies in
regard to the amount of regenerated bone with DBM, the aim
of this study was to determine the osteoconductive capability
of DBM when used as an onlay graft through quantifying
the amount of newly generated bone.2. Materials and methods
The Animal Care Committee and the Ethics Subcommittee of
the university approved the current study. Eight Adult New
Zealand White (NZW) rabbits were used in the study. The rab-
bits’ bone remodeling cycle (sigma) is 6 weeks. The human
sigma value is 17 weeks. Using the sigma ratio between human
and rabbit, conclusions can be extrapolated from the rabbit
model to human equivalents 16.
Each rabbit received two titanium bone graft holders
(TBGHs), and each holder possessed two chambers. This pro-
vided four chambers per animal; two control on one side of the
jaw and two experimental on the other side. Experimental and
control TBGH placement was randomized to jaw side.
2.1. Titanium bone graft holder (TBGH)
The titanium bone graft holder was fabricated from titanium
alloy (Ti-6Al-4V) and possessed two chambers, which had
numerous perforations (0.75 mm diameter). Each chamber
was 3 mm in height and 5 mm in diameter, and had an internal
volume of 58.9 mm 3. Six holes along the periphery of the base
enabled rigid ﬁxation of the TBGH, to the mandible, by screws
(Fig. 1A).
2.2. Surgical procedure
Eight mature New Zealand white rabbits (3.5–4 kg) underwent
bilateral mandibular surgery. The rabbits were prepared and
draped, using standard aseptic techniques. They were sedated
and then maintained under general anesthesia (Isoﬂurane 2–
4%) for the duration of the surgery. Cefazolin (12.5 mg/kg
IV, Novopharm Ltd., Toronto, Canada) was administered
intraoperatively to all rabbits.
The lateral aspect of the body and ramus of the mandible
was exposed by a 3 cm submandibular incision. To facilitate
preparation of the recipient site and positioning of the TBGH,
a template was fabricated from the base of a TBGH and
secured to the lateral aspect of the mandible with two screws
(Fig. 1B). The template was positioned so that one chamber
was on the body of the mandible and one was on the ramus.
To expose the chamber to the marrow space, four holes
(0.8 mm diameter) were drilled through the mandibular cortex,
so that they would be positioned under each chamber. On the
experimental side, both titanium chambers were ﬁlled with
DBM (Bio-Oss, Geistlich Pharmaceutical AG, Walhusen,
Switzerland) cancellous granules, (particle size 0.25–1 mm)
(Fig. 1C). The TBGH was then ﬁxed to the mandible with
six titanium screws (Stryker, Hamilton, Canada) (Fig. 1D).
On the control side the same procedure was repeated, except
that the chambers were left empty. On both the control and
experimental sides, a layer of collagen membrane (Bio-Gide,
Geistlich Pharmaceutical AG, Walhusen, Switzerland) was
Fig. 1 (A). Photograph of the titanium bone graft holder (TBGH). Visible are the two titanium chambers with numerous perforations
and six peripheral holes for screw ﬁxation. (B) Placement of the template on the mandible. Perforations in the cortical bone under each
chamber can be seen. (C) Chambers being ﬁlled with Bio-Oss bovine particulate. (D) TBGH ﬁxed in position on the mandible. Scale
bar = 5 mm.
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incisions were closed in three layers: periosteum (3–0 Vicryl),
muscle, and skin (4–0 Monocryl).2.3. Terminal procedures
All animals were sacriﬁced 12 weeks after surgery by injection
of Pentobarbital (J. M. Loveridge p.l.c., Southampton, UK) at
a dose of 150 mg/kg. Butorphanol (Apothecon B.V., Barne-
veld, Netherlands) 0.3 mg/kg was given for sedation prior to
the sacriﬁce. The mandibles were dissected bilaterally and a
portion of the mandible containing the TBGH was resected.
The titanium chambers were carefully removed. In most cases,
soft tissue was tenaciously attached to the interior of the
TBGH chambers and was removed with the TBGH. The
resected portions of the mandible were then immediately ﬁxed
in 4% formaldehyde for seventy-two hours. High-resolution
radiographs were obtained (Faxitron MX-20, Faxitron Corp.,
Lincolnshire, IL). The specimens were then dehydrated in
ascending solutions of ethanol and defatted in a 1:1 mixture
of ether and acetone prior to embedding in methylmethacry-
late (MMA).2.4. Radiographic analysis
High-resolution radiographs, which were obtained at 20 kV
for 15 s using a portable digital X-ray cabinet (Faxitron
MX-20, Faxitron Corp., Lincolnshire, IL), were analyzed in
Image J (version 1.37, NIH, Bethesda, USA). New bone for-
mation and/or DBM were clearly visible above the mandible
following the general internal shape of the chamber. For calcu-
lations of area and height, the region of interest was the base of
the newly formed bone toward the outer surface of the mandi-
ble, then the maximum width and height of the radio-opaque
region. The region of interest was manually traced followed
by automatic calculation by the image J software, which
converted pixel to mm2.2.5. Histomorphometric analysis
Using a microtome (Leica, Richmond Hill, Canada), the
embedded bone blocks were sectioned to produce 5 lm thick
slices. The sections were cut in a plane perpendicular to the
outer cortex of the mandible. Two representative sections from
the center of the graft were selected for histomorphometric
analysis and mounted on slides. All sections were then stained
with Von Kossa and Toluidine blue.
An image of the histological slides was captured using a
digital camera connected to a light microscope with a 2.5·
magniﬁcation. Image J software (version 1.37, NIH, Bethesda,
USA) was used to conduct the histomorphometric analysis.
The 3 mm high chambers were divided into two 1.5 mm high
regions (upper and lower) for analysis of the distribution of
bone in the chambers. All the areas that stained positively with
the Von Kossa stain were considered to be newly generated
bone as was illustrated in other studies 17. The region of inter-
est was manually traced followed by automatic calculation by
the image J software, which converted pixel to mm2.
2.6. Image J software
It is the imaging software (version 1.37, NIH, Bethesda, USA)
that calculates trabecular, cross-sectional and particulate
parameters in a convenient format independent of any scanner
devices. Its limitation is mainly in handling images with max-
imum of 2G pixels. It has been documented that it is a valid
and reliable tool in providing quantitative measurements from
a large number of bone images 18.
2.7. Statistical analysis
The entire statistical analysis for the study was carried out
using the Wilcoxon signed-rank test; the conﬁdence level was
95% with a level of signiﬁcance of p 6 0.05. All the results
for the sixteen chambers for the experimental group are pooled
together, and the same for the control group.
Fig. 2 Photographs of mandibles at 12 weeks. After careful removal of the titanium graft holder (TBGH), tissue within the chambers is
visible. Representative side views of (A) Bio-Oss and (B) control specimens. Titanium particles (black) are visible and are the result of
trimming the TBGH with a burr. Scale bar = 5 mm.
Fig. 3 Radiographs of samples at 12 weeks, obtained after removal of the titanium graft holder (TBGH). Radiographs shown are the
experimental and control samples from 2 animals. Note that there are 2 Bio-Oss and 2 control pairs per animal. Rabbit 1 – (A)
(Bio-Oss), (B) (control). Rabbit 2 – (C) (Bio-Oss), d (control). Chambers that received Bio-Oss (A and C) had a greater radio-dense area
and height compared to the controls chambers (B & D). Scale bar = 5 mm. Radio-dense area (E) and radio-dense height (F) were
signiﬁcantly greater for the Bio-Oss vs. the control chambers.
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There were no post-operative complications, signs of infection
or abnormal tissue growth. All specimens were retrieved for
analysis. Upon gross examination, all the chambers were com-
pletely ﬁlled with a mixture of soft and hard tissue. The exper-
imental chambers contained more hard tissue than the controls
(Fig. 2). When present, soft tissue was concentrated in the
upper part of the chambers. Most of the soft tissue within
the chambers was tenaciously attached to the interior surface
of the titanium and, as a result, was removed attached to the
TBGH. In the experimental chambers, DBM particles were
clearly visible in the generated tissue.
High-resolution digital radiographs of the specimens con-
ﬁrmed the presence of bone formation in the control group
and the presence of particles, consistent with DBM, and newly
formed bone in the experimental group (Fig. 3A–D).Upon quantiﬁcation of the radio-dense area from the
radiographs, there was signiﬁcantly more bone and/or graft
in the experimental group (12.96 mm2 ± 1.48) than the control
group (8.59 mm2 ± 3.54) (p< 0.001, Fig. 3E). Similarly, the
DBM chambers were ﬁlled to a signiﬁcantly greater height
(2.73 mm± 0.24) than the control chambers (1.83 mm
± 0.72) (p< 0.001, Fig. 3F).
In both control and experimental chambers, soft tissue was
present and seemed to grow downward from the top inner
surface of the TBGH. From the radiographic analysis this was
calculated as internal chamber height (3.0 mm) minus the aver-
age radio-dense height, leaving a distance that was ﬁlled with
non-osseous tissue. On average, soft tissue occupied the upper-
most 0.27 mmof theDBMchambers and 1.17 mmof the control
chambers. This difference was statistically different (p< 0.001).
Representative sections from the experimental and control
chambers are shown in Fig. 4. In the experimental chambers,
Fig. 4 Representative images of histological sections from 2 different animals. Sections were stained with Von Kossa (black for bone)
and Toluidine blue (violet for soft tissue) and were obtained by cutting 5–7 lm slices through the central portion of the chamber,
perpendicular to the mandibular surface. Images (A and C) are sections from chambers that contained Bio-Oss, whereas B and D were
controls. New bone formation (black) generally followed the shape of the chamber and possessed a trabecular-like appearance.
Qualitatively, bone distribution appeared more uniform and in greater amount in the Bio-Osschambers (A and C). Particulate loss was
visible throughout the Bio-Osssamples. An example of the space left by one disrupted particle is indicated by the symbol (*) in each of
images (A and C). Scale bar = 1 mm.
Table 1 The means for the area of newly formed bone, expressed in mm2 and as a percentage of the total area of the chambers.
Group Bio-Oss (mm2) Control (mm2) Bio-Oss (%) Control (%)
Upper half 0.67 ± 0.42 0.10 ± 0.15 5.12 ± 3.4% 0.81 ± 1.18%
Lower half 1.75 ± 0.53 0.59 ± 0.34 13.28 ± 4.06 % 4.5 ± 2.59 %
Total 2.43 ± 0.87 0.70 ± 0.43 18.41 ± 6.57% 5.31 ± 3.3%
Fig. 5 Percentage of new bone in the upper and lower half of the
Bio-Oss group and in the control group.
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DBM particles and appeared to fracture the bone-DBM inter-
face. New bone formation was present throughout the sec-
tions, in a trabecular pattern. In the experimental sections,bone appeared to surround and join spaces that contained
adjacent (dislodged) DBM particles. In the control chambers
there was less bone. Most control chambers had little if any
bone in the central portion of the sections and the pattern of
bone formation demonstrated few interconnections.
The means for the area of newly formed bone, expressed as
an absolute value (mm2), and as a percentage of the total area
of the chambers, are tabulated in Table 1 and presented in
Fig. 5. The mean area of newly generated bone was 18.41%
for the experimental group and 5.31% for the control group.
The difference between the two groups was statistically signif-
icant (p< 0.001). The amount of bone in the upper half of the
experimental chambers was equal to 5.12% of the total area,
while bone in the lower half of the chambers was equal to
13.28% of the total area. The difference between the amount
of bone generated in the upper and lower chambers was statis-
tically signiﬁcant (p 6 0.001). For the control group, the
amount of bone in the upper half of the chamber equaled
0.81% of the total area, while the lower half of the chamber
equaled 4.5% bone ﬁll of the total area. The difference
138 B.A. Al-jandan et al.between these two groups was statistically signiﬁcant
(p 6 0.001).4. Discussion
In the present study, the ﬁnding that the presence of DBM
particles promoted new bone formation supports previous
reports in animal studies 14 and human studies 19. The amount
of new bone within the experimental chambers (18.4%) was
similar to that reported by other studies 12,14. For example,
Slotte and Lundgren 14 found that the DBM group achieved
an average of 19.62% new bone formation, after a healing
period of twelve weeks.
In a guided bone regeneration study in the rat mandibles,
signiﬁcantly less bone formation was found in the experimental
group than in the control group, after eight and sixteen weeks
of healing 11. These investigators concluded that DBM inhibits
bone formation and is less osteoconductive than the barrier
material itself. They attributed their ﬁndings to the fact that,
although DBM is a biocompatible material, its presence inhib-
its bone formation by occupying a space, which would be
available for new bone formation 11. Another explanation
for such ﬁnding could be based on the presence of Teﬂon that
was used by the bone forming cells as a template for new bone
formation, while in the experimental group, DBM occupied
the space so the bone forming cells were not guided by the
Teﬂon capsule.
In a rat skull model, Slotte and Lundgren 13 used histomor-
phometry to study the bone generation potential of silicone
domes grafted with DBM, compared to empty domes and
demonstrated that DBM arrested bone formation. In this
study, the chambers were positioned over the sagittal suture.
Therefore, growth of soft tissue from the suture may have
competed with bone formation. Moreover, the relatively com-
pliant nature of the silicone device, and the biology of the tis-
sue response to silicone may have also contributed to the
negative results 14.
In the present study, the DBM particles in the chamber
were surrounded by newly formed bone. Only the upper
10% of the chamber (furthest from the mandible) was ﬁlled
with a mixture of DBM and ﬁbrous tissue. In comparison,
the control chambers had less bone and more ﬁbrous tissue.
Fibrous tissue was not present in the lower regions of the
chamber (closest to the mandible) but was present in the upper
39%. It is important to note that in the sections prepared from
both the control and experimental chambers, ﬁbrous tissue was
not visible as it separated from the chamber area and remained
attached to the TBGH during sample harvest. Since a barrier
membrane was used in this study, we propose that the ﬁbro-
blasts originated from the marrow and progressed along the
surface of the TBGH forming tissue from the top of the cham-
ber toward the mandible. In this study it would appear that
DBM might reduce ﬁbrous tissue formation by acting as void
ﬁller.
These ﬁndings are in agreement with the ﬁndings of Slotte
and Lundgren 14 who reported that more particles of DBM
were surrounded by new bone in the lower two thirds of a
chamber than in the upper thirds where particles were
surrounded mainly by ﬁbrous tissue. This ﬁnding may have
clinical signiﬁcance if the surface of a dental implant insertedinto the generated tissue, which is connective tissue and not
bone.
Clinically, the rationale for grafting is to increase bone
volume adjacent to the endosseous implants to ensure com-
plete coverage. In a randomized controlled clinical trial, Mor-
denfeld et al. found 82.1– 82.3% of new bone after 7.5 months
of grafting using a mixture of DBM and autogenous bone in
two different compositions (60:40 and 90:10 respectively) 4.
In our study, the radiographic and histologic data indicated
that bone formation was most reproducible in regions closest
to the jaw. For both the experimental and control chambers,
new bone formation quantiﬁed by histomorphometry was
the greatest in the ﬁrst half of the chamber (1.5 mm from the
jaw). In the lower 1.5 mm of the chamber, the experimental
sample had approximately 3 times more new bone than the
control and approximately 6 times more new bone in the upper
1.5 mm. Radiographic analysis enabled quantiﬁcation of
chamber ﬁlling (height and area). The radiodense area
appeared to be larger and more uniform in the experimental
compared to the control chambers. Although the radiodense
material extended 2.7 mm from the host bone in the experi-
mental compared to 1.7 mm in the control, still it is difﬁcult
to differentiate radiographically between DBM particles and
the natural bone due to the comparable radio-opacity 20.
5. Conclusion
DBM can enhance greater new bone formation when used as
an onlay graft, underneath a rigid barrier.
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